The chemotherapeutic galvanostat/potentiostat (CGP) is a  patent protected invention in the United States of America and Canada, with patent cooperation treaty disclosure, effectively making the CGP unpatentable in the rest of the World.

​

​

​

​

​

​

​

​

Figure 1. The World of Innovative Potential. White: patent zone; Green: disclosure zone.

Expiry: 2038

​

The patents created by Innovative Potential™ differentiated themselves from previous works by specializing the CGP hardware for a surgical environment by:

1. incorporating safety design elements and fail-safes to the CGP,

2. incorporating standardized inter-connectivity with other equipment,

3. introducing the capacity for CGP embodiment as a handheld tool,

4. introducing the capacity for CGP integration with auto-sampling laboratory robotics, and,

5. introducing the capacity for CGP integration with surgical robotics.

​